Trial Profile
Clinical Trials Insight: 700013375
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 15 Jun 2006
Price :
$35
*
At a glance
- Drugs IDM 2 (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors IDM Pharma
- 15 Jun 2006 New trial record.